Home
Conditions
Recurrent Grade 2 Follicular Lymphoma

Clinical trial condition

Recurrent Grade 2 Follicular Lymphoma

Explore clinical trials studying Recurrent Grade 2 Follicular Lymphoma. Study availability and eligibility vary by location and protocol.

109 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Grade 2 Follicular Lymphoma trial results

Completed

Bendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory or Recurrent Lymphoma or Multiple Myeloma

NCT01110135

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +80 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant

NCT00795769

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adnexal Diseases, Adult Acute Lymphoblastic Leukemia in Remission, +202 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Rituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hodgkin Lymphoma

NCT00244855

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Contiguous Stage II Grade 1 Follicular Lymphoma, +40 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies

NCT01427881

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), +138 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer

NCT00049504

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +160 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

NCT00408681

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adnexal Diseases, Adult Acute Lymphoblastic Leukemia in Remission, +221 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma

NCT00438880

Conditions: Adult Non-Hodgkin Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +39 more
Locations: University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma

NCT01748721

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +103 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

Children's Hospital of Orange County Orange, California, United States

University of California San Francisco Medical Center - Parnassus San Francisco, California, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

View all 20 locations

View Trial Details

Completed

Bortezomib in Treating Patients With Lymphoproliferative Disorders

NCT00023764

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies

NCT01658319

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +85 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Recurrent Grade 2 Follicular Lymphoma

Recurrent Grade 2 Follicular Lymphoma trial results

Related conditions